Candida albicans infections range from superficial to systemic and are one of the leading
causes of fungus-associated nosocomial infections. The innate immune responses during …

Pseudomonas aeruginosa and Staphylococcus aureus are the two most prevalent bacteria
species in the lungs of cystic fibrosis (CF) patients and are associated with poor clinical …

Pseudomonas aeruginosa can efficiently adapt to changing environmental conditions due to
its ubiquitous nature, intrinsic/acquired/adaptive resistance mechanisms, high metabolic …

Infections that involve interkingdom microbial communities, such as those between bacteria
and yeast pathogens, are difficult to treat, associated with worse patient outcomes, and may …

Background: To determine the distribution and antimicrobial susceptibility pattern of
pathogenic bacteria in patients with chronic cutaneous wounds on a national scale …

It is well known that the opportunistic pathogenic yeast, Candida albicans, can form
polymicrobial biofilms with a variety of bacteria, both in vitro and in vivo, and that these …

Mixed-species biofilm is one of the most frequently recorded clinical problems. Mixed
biofilms develop as a result of interactions between microorganisms of a single or multiple …

Background The co-existence of Candida albicans with the bacteria in the host tissues and
organs displays interactions at competitive, antagonistic, and synergistic levels. Several …

Pseudomonas aeruginosa is one of the most dominant pathogens in cystic fibrosis (CF)
airway disease and contributes to significant inflammation, airway damage, and poorer …

The microbial world represents a phenomenal diversity of microorganisms from different
kingdoms of life, which occupy an impressive set of ecological niches. Most, if not all …